Clvs stocktwits

OR: "their" "there" "their" OR "there". This browser is no longer supported at MarketWatch.

Top Analyst Stocks Popular. Bitcoin Popular. Gold New. Unusual Options Activity Popular. Research Tools. Economic Indicators. Inflation Rate Unemployment Rate.

Clvs stocktwits

Clovis Oncology Inc. There looks to be no company news acting as a catalyst that moved the share price, but likely the stock moved as retail traders pushed it. The stock was trending on social media sites such as StockTwits. Clovis Oncology was down 1. Bullish traders would like to see the stock bounce off of support and start moving back higher. Bulls would then like to see the stock break above resistance for a potential trend change. Bulls would also like to see the stock break above the moving averages for a change in sentiment. Bearish traders would like to see the stock continue to hold below the pattern resistance. If the stock can stay below pattern resistance for the entirety of the pattern, then the pattern may confirm and the stock may see a large bearish drop in time. Search markets. News The word News.

Dividend Calculator.

Top Analyst Stocks Popular. Bitcoin Popular. Gold New. Unusual Options Activity Popular. Research Tools. Economic Indicators. Inflation Rate Unemployment Rate.

The movement in CLVS stock is largely being driven by online chatter, as no announcement has been made concerning an acquisition. There is also a report on Seeking Alpha today about the possible takeover, further intensifying interest in CLVS stock. Talk of a takeover comes after Clovis announced positive results last week from two Phase 3 clinical trials involving medications used to treat metastatic ovarian cancer and prostate cancer. The clinical trial results were greeted enthusiastically by investors, leading to a brief bounce in CLVS stock. Clovis Oncology is a small pharmaceutical startup that has never commercialized a medication and successfully brought it to market. Also, CLVS stock has proven to be popular with retail traders , who have executed short squeezes on it several times over the past two years. Talk of a takeover is pure speculation at this point. No deal has been announced, and there is no guarantee a purchase will ever come to fruition. Given the ups and downs of the share price in recent months, investors might want to wait and see if the rumors become fact before taking a position in CLVS stock. On the date of publication, Joel Baglole did not have either directly or indirectly any positions in the securities mentioned in this article.

Clvs stocktwits

Pfizer has two products with great potential, waiting on phase-3 study results. The resulting revenue increase should also improve share value. The company inks a stalking horse agreement with Novartis for one of its pipeline candidates. Clovis Oncology, Inc. Clovis CLVS reported earnings 30 days ago.

Microsoft reward points

Most Visited Websites. Federal Funds Rate. Auto Loan Calculator. Mobile APP. Options Market Overview. Contact Us. Currently, no data Available. Stock Splits. This browser is no longer supported at MarketWatch. OR: "their" "there" "their" OR "there". Trending Stocks. Top Financial Bloggers.

The company partially adjourned its annual shareholder meeting, originally on June 9, until today.

Top Insiders Stocks. Dividend Calendar. About TipRanks. Enter Ticker. Top Smart Score Stocks Popular. ETF Screener Popular. Auto Loan Calculator. Penny Stock Screener. Dividends Dividend Center. Unemployment Rate. Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page. Clovis Oncology Inc.